Drug profile · INN
ranibizumab-leyk
NUFYMCO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ranibizumab-leyk (NUFYMCO) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
INN ranibizumab-leyk
Brand NUFYMCO
Formulation INJECTION
Frequently asked questions
What is ranibizumab-leyk?
ranibizumab-leyk (NUFYMCO) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for ranibizumab-leyk?
NUFYMCO is a marketed brand name for ranibizumab-leyk. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ranibizumab-leyk?
ranibizumab-leyk has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.